Prenatal diethylstilbestrol exposure and mammographic density
- 2 May 2018
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 143 (6) , 1374-1378
Abstract
In a prospective cohort study of the health effects associated with prenatal Diethylstilbestrol (DES) exposure, DES was associated with an increased breast cancer risk after 40 years of age. It is unknown whether it is associated with greater mammographic density, which strongly predicts breast cancer risk. A cohort of DES‐exposed and unexposed women was assembled at the Mayo Clinic in 1975, and followed through 2012 as part of the National Cancer Institute's DES follow‐up study. Mammographic density from 3,637 mammograms for 332 (222 DES‐exposed, 110 unexposed) women in this cohort screened at the Mayo Clinic, Rochester between 1996 and 2015 was determined clinically using the Breast Imaging Reporting and Data System (BI‐RADS). Any effect of prenatal DES exposure on mammographic density was estimated using repeated measures logistic regression. There was no association between prenatal DES exposure and high mammographic density for either premenopausal [Odds ratios (OR) = 0.92 (95% Confidence Interval (CI): 0.50, 1.7] or postmenopausal women (OR = 0.90; 95% CI: 0.54, 1.5). Among premenopausal women, associations differed by body mass index (BMI), with ORs of 1.47 (0.70, 3.1) for women with BMI above the median and 0.53 (0.23, 1.3) for those with BMI below the median (pinteraction = 0.05). Overall, however, prenatal DES exposure was not associated with high mammographic density in this sample of DES Study participants. Consequently, this study does not provide evidence that high mammographic density is involved with the influence of DES on breast cancer risk.Keywords
Funding Information
- National Cancer Institute (HHSN261201500029C, HHSN261201500026C)
This publication has 19 references indexed in Scilit:
- Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tractAmerican Journal of Obstetrics and Gynecology, 2016
- Odds per Adjusted Standard Deviation: Comparing Strengths of Associations for Risk Factors Measured on Different Scales and Across Diseases and Populations: Table 1.American Journal of Epidemiology, 2015
- Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughtersBreast Cancer Research, 2014
- Bisphenol A alters the development of the rhesus monkey mammary glandProceedings of the National Academy of Sciences, 2012
- Adverse Health Outcomes in Women Exposed In Utero to DiethylstilbestrolNew England Journal of Medicine, 2011
- Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidenceBreast Cancer Research, 2008
- Prenatal Diethylstilbestrol Exposure and Risk of Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2006
- Endogenous Sex Hormone Levels and Mammographic Density among Postmenopausal WomenCancer Epidemiology, Biomarkers & Prevention, 2005
- Estrogen-Plus-Progestin Use and Mammographic Density in Postmenopausal Women: Women's Health Initiative Randomized TrialJNCI: Journal of the National Cancer Institute, 2005
- Cancer and stilbestrol. A follow-up of 1,719 persons exposed to estrogens in utero and born 1943-1959.1973